179 related articles for article (PubMed ID: 33816577)
1. Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.
Hamada M; Bhakta V; Andres SN; Sheffield WP
Front Cardiovasc Med; 2021; 8():647405. PubMed ID: 33816577
[TBL] [Abstract][Full Text] [Related]
2. Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis.
Bhakta V; Hamada M; Nouanesengsy A; Lapierre J; Perruzza DL; Sheffield WP
Sci Rep; 2021 Mar; 11(1):5565. PubMed ID: 33692375
[TBL] [Abstract][Full Text] [Related]
3. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
4. The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of alpha1-proteinase inhibitor M358R for thrombin.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Haemost; 2007 Nov; 98(5):1014-23. PubMed ID: 18000606
[TBL] [Abstract][Full Text] [Related]
5. Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition.
Roddick LA; Bhakta V; Sheffield WP
BMC Biochem; 2013 Nov; 14():31. PubMed ID: 24215622
[TBL] [Abstract][Full Text] [Related]
6. Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Sheffield WP; Eltringham-Smith LJ; Bhakta V; Gataiance S
Thromb Haemost; 2012 May; 107(5):972-84. PubMed ID: 22370677
[TBL] [Abstract][Full Text] [Related]
7. The M358R variant of α(1)-proteinase inhibitor inhibits coagulation factor VIIa.
Sheffield WP; Bhakta V
Biochem Biophys Res Commun; 2016 Feb; 470(3):710-713. PubMed ID: 26797521
[TBL] [Abstract][Full Text] [Related]
8. Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin.
Scott BM; Matochko WL; Gierczak RF; Bhakta V; Derda R; Sheffield WP
PLoS One; 2014; 9(1):e84491. PubMed ID: 24427287
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity.
Gierczak RF; Bhakta V; Xie M; Sheffield WP
J Biotechnol; 2015 Aug; 208():54-62. PubMed ID: 26043905
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Protein Z-Dependent Protease Inhibitor/Antithrombin Chimeras Provides Insight into the Serpin Specificity of Coagulation Proteases.
Yang L; Rezaie AR
ACS Omega; 2017 Jul; 2(7):3276-3283. PubMed ID: 28782047
[TBL] [Abstract][Full Text] [Related]
11. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
Sutherland JS; Bhakta V; Filion ML; Sheffield WP
Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
[TBL] [Abstract][Full Text] [Related]
12. Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity.
Bhakta V; Gierczak RF; Sheffield WP
J Biotechnol; 2013 Dec; 168(4):373-81. PubMed ID: 24140600
[TBL] [Abstract][Full Text] [Related]
13. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
Wuillemin WA; Eldering E; Citarella F; de Ruig CP; ten Cate H; Hack CE
J Biol Chem; 1996 May; 271(22):12913-8. PubMed ID: 8662679
[TBL] [Abstract][Full Text] [Related]
14. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
15. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
[TBL] [Abstract][Full Text] [Related]
16. Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.
Schmidt AE; Ogawa T; Gailani D; Bajaj SP
J Biol Chem; 2004 Jul; 279(28):29485-92. PubMed ID: 15090552
[TBL] [Abstract][Full Text] [Related]
17. A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss.
Sheffield WP; Eltringham-Smith LJ; Bhakta V
BMC Biotechnol; 2018 Apr; 18(1):21. PubMed ID: 29621998
[TBL] [Abstract][Full Text] [Related]
18. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
[TBL] [Abstract][Full Text] [Related]
19. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
Rezaie AR; Sun MF; Gailani D
Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.
Navaneetham D; Sinha D; Walsh PN
J Biochem; 2010 Oct; 148(4):467-79. PubMed ID: 20647553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
